Select Page

Innovations in Non-Invasive Stone Treatment

Each year, more than three million Americans see a physician for kidney stones and over 700,000 procedures are performed to break large kidney stones.

SonoMotion is developing non-invasive solutions for kidney stone disease with two breakthrough products:

Break Wave™

Break Wave will fragment large kidney stones faster, safer and more effectively than existing options.*

Stone Clear™

Stone Clear will help clear residue fragments within 15 minutes in an office setting without anesthesia.* 

Latest News

March 26th, 2019

SonoMotion receives Health Canada ITA approval to initiate its Break WaveTM First-In-Human clinical trial in Canada.

December 14th, 2018

SonoMotion receives FDA IDE approval to initiate its Break WaveTM First-In-Human clinical trial in the United States.

October 31st, 2017

GE Healthcare and SonoMotion establish a strategic partnership and sign a definitive OEM agreement and co-development agreement.

August 1st, 2017

SonoMotion receives a $1.0M SBIR Commercial Readiness Program grant from the NIH for the development of Stone ClearTM.

April 7th, 2017

SonoMotion closes on a $4.6M Series-A round led by MedVenture Partners Inc. and with a significant participation by Bioventures Investors.

May 1st, 2016

SonoMotion secures a $1.75M SBIR FastTrack grant from the NIH for the development of Break WaveTM.

April 1st, 2016

SonoMotion receives a $350,000 grant from NASA and NSBRI to accelerate development of Break WaveTM.

December 2nd, 2015

SonoMotion wins Runner-Up and $50,000 in the prestigious primeUC life science startup competition organized by the University of California and Johnson & Johnson.

September 7th, 2015

Dr. Doug Corl joins SonoMotion as its Chief Technology Officer bringing over 35 years of experience in developing commercial ultrasound-based medical devices.

August 1st, 2015

 SonoMotion secures a $1.75M non-dilutive SBIR grant funding from the NIH for the development of Stone ClearTM

Management Team

Oren Levy, PhD

Chief Executive Officer

Dr. Oren Levy is an experienced medical device leader and entrepreneur with an outstanding record of achievement. Dr. Levy played a key role in the management and acquisition of Fluid Medical, an ultrasound based medical device startup, by Volcano Corporation (acquired by Philips). Dr. Levy has led and managed multi-disciplinary teams including disposable, hardware and software R&D and product marketing in both large-company and entrepreneurial environments. Dr. Levy integrates a personal background in science, operations and management consulting to introduce structure and rigor to a start-up environment. Most recently, Dr. Levy led Volcano Corporation’s Mountain View office with $3.4M annual budget supervising an eleven person team developing a percutaneous forward looking intra‐cardiac ultrasound imaging device. Dr. Levy received a PhD in Biophysics and a double BA degree in Physics and Astrophysics from UC Berkeley.

Doug Corl, PhD

Chief Technology Officer

Dr. Corl is a proven and recognized ultrasound expert with over 35 years of experience in developing and delivering commercial ultrasound-based medical devices. Dr. Corl has 38 issued patents and was either the CTO or Chief Scientist for the past 24 years at both early stage startups and large multinational ultrasound-based companies, including Volcano Corporation, Keimar, PharmaSonics and Cardiometrics. Dr. Corl received a PhD in Electrical Engineering from Stanford University and a BA and MS in Electrical Engineering from UC Irvine.

Physician Advisors

Dr. James Lingeman, MD

Indiana University

Professor of Urology and past President of the Endourological Society

Dr. Mathew Sorensen, MD, MS

University of Washington and Puget Sound VA Hospital

Associate Professor of Urology and Director of the Comprehensive Metabolic Stone Clinic

Dr. Brian Eisner, MD

Harvard Medical School - Assistant Professor of Surgery

MassGeneral – Co-Director, Kidney Stone Program

Dr. Ben Chew, MD

University of British Columbia - Associate Prof. of Urology

Vancouver General Hospital – Director of Clinical Research at the Stone Centre

Technical Advisors

Michael Bailey, PhD

University of Washington, Seattle

Faculty in Mechanical Engineering and Urology,

Senior Principal Engineer at the Applied Physics Lab and Program Director of NIH Program Projecton Lithotripsy


Barbrina Dunmire, MS

University of Washington, Seattle

Sr. Biomedical Engineer at Applied Physics Lab

Bryan Cunitz, MS

University of Washington, Seattle

Sr. Electrical Engineer at the Applied Physics Lab

Adam Maxwell, PhD

University of Washington, Seattle

Research Assistant Professor of Urology


Fragmentation of stones by Burst Wave Lithotripsy in the first 19 humans
Harper JD, Lingeman JE, Sweet RM, Metzler IS, Sunaryo PL, Williams JC Jr, Maxwell AD, Thiel J, Cunitz BW, Dunmire B, Bailey MR, Sorensen MD. J Urol. 2022 May;207(5):1067-1076.

Recent Advances in the Science of Burst Wave Lithotripsy and Ultrasonic Propulsion
D Raskolnikov, Bailey MR, Harper JD.    BME Frontiers Volume 2022. Article ID 9847952

Fragmentation of Urinary Calculi In Vitro by Burst Wave Lithotripsy
Maxwell AD, Cunitz BW, Kreider W, Sapozhnikov O, Hsi RS, Harper JD, Bailey MR, Sorensen MD. J Urol. 2015 Jan;193(1):338-44

Bursting through limitations of SWL
Thoma C. Nat Rev Urol. 2014 Oct;11(10):540

Combined Burst Wave Lithotripsy and Ultrasonic Propulsion for Improved Urinary Stone Fragmentation
Zwaschka TA, Ahn JS, Cunitz BW, Bailey MR, Dunmire B, Sorensen MD, Harper JD, Maxwell AD. J Endourol. 2018 Apr;32(4):344-349

Detection and Evaluation of Renal Injury in Burst Wave Lithotripsy Using Ultrasound and Magnetic Resonance Imaging
May PC, Kreider W, Maxwell AD, Wang YN, Cunitz BW, Blomgren PM, Johnson CD, Park JSH, Bailey MR, Lee D, Harper JD, Sorensen MD. J Endourol. 2017 Aug;31(8):786-792

First-in-human feasibility trial for ultrasonic propulsion of kidney stones
Harper JD, Cunitz BW, Dunmire B, Lee FC, Sorensen MD, Hsi RS, Thiel J, Wessells H, Lingeman JE, Bailey MR. J Urol. 2016 Apr;195(4):956-964

Ultrasonic propulsion of kidney stones – Review
May PC, Bailey MR, Harper JD. Curr Opin Urol. 2016 May;26(3):264-70

Preclinical safety and effectiveness studies of ultrasonic propulsion of kidney stones
Harper JD, Dunmire B, Wang YN, Simon JC, Liggitt D, Paun M, Cunitz BW, Starr F, Bailey MR, Penniston KL, Lee FC, Hsi RS, Sorensen MD. Urology. 2014 Aug;84(2):484-9

Use of the acoustic shadow width to determine kidney stone size with ultrasound
Dunmire B, Harper JD, Cunitz BW, Lee FC, Hsi R, Liu Z, Bailey MR, Sorensen MD. J Urol. 2016 Jan;195(1):171-7

Improved detection of kidney stones using an optimized Doppler imaging sequence
Cunitz B, Dunmire B, Paun M, Sapozhnikov O, Kucewicz J, Hsi R, Lee F, Sorensen M, Harper J, Bailey M. IEEE Int Ultrason Symp. 2014 Sep 3;2014:452-455

Contact Us

1600 West Hillsdale Boulevard, Suite 105 San Mateo, CA 94402

Dr. Oren Levy, CEO